🇺🇸 FDA
Patent

US 11629348

Linkage modified oligomeric compounds and uses thereof

granted A61KA61K31/015A61K31/05

Quick answer

US patent 11629348 (Linkage modified oligomeric compounds and uses thereof) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/015, A61K31/05, A61K31/352, A61K45/06